Skip to main navigation menu Skip to main content Skip to site footer
##common.pageHeaderLogo.altText##

Review article: Biomedical intelligence

Vol. 154 No. 11 (2024)

E-cigarettes, synthetic nicotine, heated-tobacco and smokeless nicotine delivery products: the nicotine landscape beyond combustible cigarettes

DOI
https://doi.org/10.57187/s.3583
Cite this as:
Swiss Med Wkly. 2024;154:3583
Published
04.11.2024

Summary

Cigarette smoking remains an enormous public health problem causing millions of preventable deaths annually worldwide. Although safe and efficient smoking cessation pharmacotherapies such as nicotine replacement products and the medications varenicline and bupropion are available, long-term abstinence rates remain low and new approaches to help smokers successfully quit smoking are needed. In recent years, electronic nicotine delivery systems such as e-cigarettes and heated-tobacco products, and novel smokeless nicotine delivery products like nicotine pouches have gained widespread popularity. These products can deliver nicotine without combustion of tobacco and might thus present an alternative to the currently available smoking cessation methods if they prove able to help smokers quit smoking conventional cigarettes while decreasing their exposure to toxicants. In this narrative review, we provide a summary of the characteristics of these novel nicotine delivery products and the available data regarding their efficacy as smoking cessation tools and safety profile with a focus on the current situation in Switzerland.

References

  1. World Health Organization (WHO). Tobacco, Overview. 2024; Available from: https://www.who.int/health-topics/tobacco#tab=tab_1
  2. Federal Department of Home Affairs FDHA. Zahlen & Fakten: Tabak. 2023; Available from: www.bag.admin.ch
  3. Joossens L, Olefir L, Feliu A, Fernandez E. The Tobacco Control Scale 2021 in Europe, C.I.o.O. Brussels: Smoke Free Partnership, Editor. 2022.
  4. Benowitz NL. Nicotine addiction. N Engl J Med. 2010 Jun;362(24):2295–303. doi: https://doi.org/10.1056/NEJMra0809890 DOI: https://doi.org/10.1056/NEJMra0809890
  5. Rigotti NA, Kruse GR, Livingstone-Banks J, Hartmann-Boyce J. Treatment of Tobacco Smoking: A Review. JAMA. 2022 Feb;327(6):566–77. doi: https://doi.org/10.1001/jama.2022.0395 DOI: https://doi.org/10.1001/jama.2022.0395
  6. Prochaska JJ, Benowitz NL. Current advances in research in treatment and recovery: nicotine addiction. Sci Adv. 2019 Oct;5(10):eaay9763. doi: https://doi.org/10.1126/sciadv.aay9763 DOI: https://doi.org/10.1126/sciadv.aay9763
  7. Rigotti NA. Strategies to help a smoker who is struggling to quit. JAMA. 2012 Oct;308(15):1573–80. doi: https://doi.org/10.1001/jama.2012.13043 DOI: https://doi.org/10.1001/jama.2012.13043
  8. Benowitz NL. Clinical pharmacology of nicotine: implications for understanding, preventing, and treating tobacco addiction. Clin Pharmacol Ther. 2008 Apr;83(4):531–41. doi: https://doi.org/10.1038/clpt.2008.3 DOI: https://doi.org/10.1038/clpt.2008.3
  9. Auer R, Diethelm P, Berthet A. Heating Tobacco Sticks Instead of Combusting Conventional Cigarettes and Future Heart Attacks: Still Smoke, and Risk. Circulation. 2021 Nov;144(19):1539–42. doi: https://doi.org/10.1161/CIRCULATIONAHA.121.056959 DOI: https://doi.org/10.1161/CIRCULATIONAHA.121.056959
  10. Chen W, Wang P, Ito K, Fowles J, Shusterman D, Jaques PA, et al. Measurement of heating coil temperature for e-cigarettes with a “top-coil” clearomizer. PLoS One. 2018 Apr;13(4):e0195925. doi: https://doi.org/10.1371/journal.pone.0195925 DOI: https://doi.org/10.1371/journal.pone.0195925
  11. Vedøy TF, Lund KE. Nicotine Content in Swedish-Type Snus Sold in Norway From 2005 to 2020. Nicotine Tob Res. 2022 Jun;24(7):1130–3. doi: https://doi.org/10.1093/ntr/ntac006 DOI: https://doi.org/10.1093/ntr/ntac006
  12. Mallock N, Schulz T, Malke S, Dreiack N, Laux P, Luch A. Levels of nicotine and tobacco-specific nitrosamines in oral nicotine pouches. Tob Control. 2024 Feb;33(2):193–9. doi: https://doi.org/10.1136/tc-2022-057280 DOI: https://doi.org/10.1136/tc-2022-057280
  13. Refdata. Swissmedic Arzneimittelinformation-Publikationssystem (AIPS); Available from: http://www.swissmedicinfo.ch/
  14. Lindson N, Butler AR, McRobbie H, Bullen C, Hajek P, Begh R, et al. Electronic cigarettes for smoking cessation. Cochrane Database Syst Rev. 2024 Jan;1(1):CD010216. DOI: https://doi.org/10.1002/14651858.CD010216.pub8
  15. Tattan-Birch H, Hartmann-Boyce J, Kock L, Simonavicius E, Brose L, Jackson S, et al. Heated tobacco products for smoking cessation and reducing smoking prevalence. Cochrane Database Syst Rev. 2022 Jan;1(1):CD013790. DOI: https://doi.org/10.1002/14651858.CD013790.pub2
  16. McNeill A, Munafò MR. Reducing harm from tobacco use. J Psychopharmacol. 2013 Jan;27(1):13–8. doi: https://doi.org/10.1177/0269881112458731 DOI: https://doi.org/10.1177/0269881112458731
  17. Bundesamt für Gesundheit BAG, Erhebung Gesundheit und Lifestyle 2022. 2023. Available from: https://www.bag.admin.ch/bag/de/home/das-bag/ressortforschung-evaluation/forschung-im-bag/forschung-nichtuebertragbare-krankheiten/monitoring-systemncd/erhebung-gesundheit-lifestyle/erhebung-gesundheit-lifestyle-2022.html
  18. Gilbert HA. Smokeless non-tobacco cigarette, U.S.P. Office, Editor. 1963. Available from: https://patents.google.com/patent/US3200819A/en
  19. Caponnetto P, Campagna D, Papale G, Russo C, Polosa R. The emerging phenomenon of electronic cigarettes. Expert Rev Respir Med. 2012 Feb;6(1):63–74. doi: https://doi.org/10.1586/ers.11.92 DOI: https://doi.org/10.1586/ers.11.92
  20. Bhatnagar A, Whitsel LP, Ribisl KM, Bullen C, Chaloupka F, Piano MR, et al.; American Heart Association Advocacy Coordinating Committee, Council on Cardiovascular and Stroke Nursing, Council on Clinical Cardiology, and Council on Quality of Care and Outcomes Research. Electronic cigarettes: a policy statement from the American Heart Association. Circulation. 2014 Oct;130(16):1418–36. doi: https://doi.org/10.1161/CIR.0000000000000107 DOI: https://doi.org/10.1161/CIR.0000000000000107
  21. Barrington-Trimis JL, Samet JM, McConnell R. Flavorings in electronic cigarettes: an unrecognized respiratory health hazard? JAMA. 2014 Dec;312(23):2493–4. doi: https://doi.org/10.1001/jama.2014.14830 DOI: https://doi.org/10.1001/jama.2014.14830
  22. Orellana-Barrios MA, Payne D, Mulkey Z, Nugent K. Electronic Cigarettes—A Narrative Review for Clinicians. Am J Med. 2015 Jul;128(7):674–81. doi: https://doi.org/10.1016/j.amjmed.2015.01.033 DOI: https://doi.org/10.1016/j.amjmed.2015.01.033
  23. Etter JF, Bullen C, Flouris AD, Laugesen M, Eissenberg T. Electronic nicotine delivery systems: a research agenda. Tob Control. 2011 May;20(3):243–8. doi: https://doi.org/10.1136/tc.2010.042168 DOI: https://doi.org/10.1136/tc.2010.042168
  24. Barua RS, Rigotti NA, Benowitz NL, Cummings KM, Jazayeri MA, Morris PB, et al. 2018 ACC Expert Consensus Decision Pathway on Tobacco Cessation Treatment: A Report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents. J Am Coll Cardiol. 2018 Dec;72(25):3332–65. doi: https://doi.org/10.1016/j.jacc.2018.10.027 DOI: https://doi.org/10.1016/j.jacc.2018.10.027
  25. Jackler RK, Ramamurthi D. Nicotine arms race: JUUL and the high-nicotine product market. Tob Control. 2019 Nov;28(6):623–8. doi: https://doi.org/10.1136/tobaccocontrol-2018-054796 DOI: https://doi.org/10.1136/tobaccocontrol-2018-054796
  26. European Commission. EU Rules on Tobacco Products. 2016; Available from: https://health.ec.europa.eu/document/download/7223d20d-4dad-451e-bcc7-ac134fb6d1d7_en?filename=tobacco_infograph2_en.pdf
  27. Taylor A, Dunn K, Turfus S. A review of nicotine-containing electronic cigarettes-Trends in use, effects, contents, labelling accuracy and detection methods. Drug Test Anal. 2021 Feb;13(2):242–60. doi: https://doi.org/10.1002/dta.2998 DOI: https://doi.org/10.1002/dta.2998
  28. Jordt SE. Synthetic nicotine has arrived. Tob Control. 2023 Apr;32 e1:e113–7. doi: https://doi.org/10.1136/tobaccocontrol-2021-056626 DOI: https://doi.org/10.1136/tobaccocontrol-2021-056626
  29. Zhang H, Pang Y, Luo Y, Li X, Chen H, Han S, et al. Enantiomeric composition of nicotine in tobacco leaf, cigarette, smokeless tobacco, and e-liquid by normal phase high-performance liquid chromatography. Chirality. 2018 Jul;30(7):923–31. doi: https://doi.org/10.1002/chir.22866 DOI: https://doi.org/10.1002/chir.22866
  30. Berman ML, Zettler PJ, Jordt SE. Synthetic Nicotine: Science, Global Legal Landscape, and Regulatory Considerations. World Health Organ Tech Rep Ser. 2023;1047:35–60.
  31. Jacob P 3rd, Benowitz NL, Copeland JR, Risner ME, Cone EJ. Disposition kinetics of nicotine and cotinine enantiomers in rabbits and beagle dogs. J Pharm Sci. 1988 May;77(5):396–400. doi: https://doi.org/10.1002/jps.2600770508 DOI: https://doi.org/10.1002/jps.2600770508
  32. Ikushima S, Muramatsu I, Sakakibara Y, Yokotani K, Fujiwara M. The effects of d-nicotine and l-isomer on nicotinic receptors. J Pharmacol Exp Ther. 1982 Aug;222(2):463–70.
  33. Nwosu CG, Godin CS, Houdi AA, Damani LA, Crooks PA. Enantioselective metabolism during continuous administration of S-(-)- and R-(+)-nicotine isomers to guinea-pigs. J Pharm Pharmacol. 1988 Dec;40(12):862–9. doi: https://doi.org/10.1111/j.2042-7158.1988.tb06289.x DOI: https://doi.org/10.1111/j.2042-7158.1988.tb06289.x
  34. Krüsemann EJ, Boesveldt S, de Graaf K, Talhout R. An E-Liquid Flavor Wheel: A Shared Vocabulary Based on Systematically Reviewing E-Liquid Flavor Classifications in Literature. Nicotine Tob Res. 2019 Sep;21(10):1310–9. doi: https://doi.org/10.1093/ntr/nty101 DOI: https://doi.org/10.1093/ntr/nty101
  35. US Food and Drug Administration. FDA finalizes enforcement policy on unauthorized flavored cartridge-based e-cigarettes that appeal to children, including fruit and mint. 2020; Available from: https://www.fda.gov/news-events/press-announcements/fda-finalizes-enforcement-policy-unauthorized-flavored-cartridge-based-e-cigarettes-appeal-children
  36. Allen JG, Flanigan SS, LeBlanc M, Vallarino J, MacNaughton P, Stewart JH, et al. Flavoring Chemicals in E-Cigarettes: Diacetyl, 2,3-Pentanedione, and Acetoin in a Sample of 51 Products, Including Fruit-, Candy-, and Cocktail-Flavored E-Cigarettes. Environ Health Perspect. 2016 Jun;124(6):733–9. doi: https://doi.org/10.1289/ehp.1510185 DOI: https://doi.org/10.1289/ehp.1510185
  37. Fujioka K, Shibamoto T. Determination of toxic carbonyl compounds in cigarette smoke. Environ Toxicol. 2006 Feb;21(1):47–54. doi: https://doi.org/10.1002/tox.20153 DOI: https://doi.org/10.1002/tox.20153
  38. White AV, Wambui DW, Pokhrel LR. Risk assessment of inhaled diacetyl from electronic cigarette use among teens and adults. Sci Total Environ. 2021 Jun;772:145486. doi: https://doi.org/10.1016/j.scitotenv.2021.145486 DOI: https://doi.org/10.1016/j.scitotenv.2021.145486
  39. Kosmider L, Sobczak A, Prokopowicz A, Kurek J, Zaciera M, Knysak J, et al. Cherry-flavoured electronic cigarettes expose users to the inhalation irritant, benzaldehyde. Thorax. 2016 Apr;71(4):376–7. doi: https://doi.org/10.1136/thoraxjnl-2015-207895 DOI: https://doi.org/10.1136/thoraxjnl-2015-207895
  40. Effah F, Taiwo B, Baines D, Bailey A, Marczylo T. Pulmonary effects of e-liquid flavors: a systematic review. J Toxicol Environ Health B Crit Rev. 2022 Oct;25(7):343–71. doi: https://doi.org/10.1080/10937404.2022.2124563 DOI: https://doi.org/10.1080/10937404.2022.2124563
  41. Erythropel HC, Jabba SV, DeWinter TM, Mendizabal M, Anastas PT, Jordt SE, et al. Formation of flavorant-propylene Glycol Adducts With Novel Toxicological Properties in Chemically Unstable E-Cigarette Liquids. Nicotine Tob Res. 2019 Aug;21(9):1248–58. doi: https://doi.org/10.1093/ntr/nty192 DOI: https://doi.org/10.1093/ntr/nty192
  42. Zervas E, Matsouki N, Kyriakopoulos G, Poulopoulos S, Ioannides T, Katsaounou P. Transfer of metals in the liquids of electronic cigarettes. Inhal Toxicol. 2020 May;32(6):240–8. doi: https://doi.org/10.1080/08958378.2020.1776801 DOI: https://doi.org/10.1080/08958378.2020.1776801
  43. Meza R, Jimenez-Mendoza E, Levy DT. Trends in Tobacco Use Among Adolescents by Grade, Sex, and Race, 1991-2019. JAMA Netw Open. 2020 Dec;3(12):e2027465. doi: https://doi.org/10.1001/jamanetworkopen.2020.27465 DOI: https://doi.org/10.1001/jamanetworkopen.2020.27465
  44. Pierce JP, Luo M, McMenamin SB, Stone MD, Leas EC, Strong D, et al. Declines in cigarette smoking among US adolescents and young adults: indications of independence from e-cigarette vaping surge. Tob Control. 2023 Nov8:tc-2022–057907. doi: https://doi.org/10.1136/tc-2022-057907 DOI: https://doi.org/10.1136/tc-2022-057907
  45. Hajek P, Pittaccio K, Pesola F, Myers Smith K, Phillips-Waller A, Przulj D. Nicotine delivery and users’ reactions to Juul compared with cigarettes and other e-cigarette products. Addiction. 2020 Jun;115(6):1141–8. doi: https://doi.org/10.1111/add.14936 DOI: https://doi.org/10.1111/add.14936
  46. O’Connell G, Pritchard JD, Prue C, Thompson J, Verron T, Graff D, et al. A randomised, open-label, cross-over clinical study to evaluate the pharmacokinetic profiles of cigarettes and e-cigarettes with nicotine salt formulations in US adult smokers. Intern Emerg Med. 2019 Sep;14(6):853–61. doi: https://doi.org/10.1007/s11739-019-02025-3 DOI: https://doi.org/10.1007/s11739-019-02025-3
  47. St Helen G, Havel C, Dempsey DA, Jacob P 3rd, Benowitz NL. Nicotine delivery, retention and pharmacokinetics from various electronic cigarettes. Addiction. 2016 Mar;111(3):535–44. doi: https://doi.org/10.1111/add.13183 DOI: https://doi.org/10.1111/add.13183
  48. Hajek P, Phillips-Waller A, Przulj D, Pesola F, Myers Smith K, Bisal N, et al. A Randomized Trial of E-Cigarettes versus Nicotine-Replacement Therapy. N Engl J Med. 2019 Feb;380(7):629–37. doi: https://doi.org/10.1056/NEJMoa1808779 DOI: https://doi.org/10.1056/NEJMoa1808779
  49. Auer R, Schoeni A, Humair JP, Jacot-Sadowski I, Berlin I, Stuber MJ, et al. Electronic Nicotine-Delivery Systems for Smoking Cessation. N Engl J Med. 2024 Feb;390(7):601–10. doi: https://doi.org/10.1056/NEJMoa2308815 DOI: https://doi.org/10.1056/NEJMoa2308815
  50. Warner KE, Benowitz NL, McNeill A, Rigotti NA. Nicotine e-cigarettes as a tool for smoking cessation. Nat Med. 2023 Mar;29(3):520–4. doi: https://doi.org/10.1038/s41591-022-02201-7 DOI: https://doi.org/10.1038/s41591-022-02201-7
  51. Caponnetto P, Campagna D, Ahluwalia JS, Russell C, Maglia M, Riela PM, et al. Varenicline and counseling for vaping cessation: a double-blind, randomized, parallel-group, placebo-controlled trial. BMC Med. 2023 Jul;21(1):220. doi: https://doi.org/10.1186/s12916-023-02919-2 DOI: https://doi.org/10.1186/s12916-023-02919-2
  52. Rigotti NA, Benowitz NL, Prochaska JJ, Cain DF, Ball J, Clarke A, et al. Cytisinicline for Vaping Cessation in Adults Using Nicotine E-Cigarettes: The ORCA-V1 Randomized Clinical Trial. JAMA Intern Med. 2024 Aug;184(8):922–30. doi: https://doi.org/10.1001/jamainternmed.2024.1313 DOI: https://doi.org/10.1001/jamainternmed.2024.1313
  53. Graham AL, Amato MS, Cha S, Jacobs MA, Bottcher MM, Papandonatos GD. Effectiveness of a Vaping Cessation Text Message Program Among Young Adult e-Cigarette Users: A Randomized Clinical Trial. JAMA Intern Med. 2021 Jul;181(7):923–30. doi: https://doi.org/10.1001/jamainternmed.2021.1793 DOI: https://doi.org/10.1001/jamainternmed.2021.1793
  54. Kundu A, Kouzoukas E, Zawertailo L, Fougere C, Dragonetti R, Selby P, et al. Scoping review of guidance on cessation interventions for electronic cigarettes and dual electronic and combustible cigarettes use. CMAJ Open. 2023 Apr;11(2):E336–44. doi: https://doi.org/10.9778/cmajo.20210325 DOI: https://doi.org/10.9778/cmajo.20210325
  55. Leung LW, Davies GA. Smoking Cessation Strategies in Pregnancy. J Obstet Gynaecol Can. 2015 Sep;37(9):791–7. doi: https://doi.org/10.1016/S1701-2163(15)30149-3 DOI: https://doi.org/10.1016/S1701-2163(15)30149-3
  56. Fahy SJ, Cooper S, Coleman T, Naughton F, Bauld L. Provision of smoking cessation support for pregnant women in England: results from an online survey of NHS Stop Smoking Services for Pregnant Women. BMC Health Serv Res. 2014 Mar;14(1):107. doi: https://doi.org/10.1186/1472-6963-14-107 DOI: https://doi.org/10.1186/1472-6963-14-107
  57. Przulj D, Pesola F, Myers Smith K, McRobbie H, Coleman T, Lewis S, et al. Helping pregnant smokers quit: a multi-centre randomised controlled trial of electronic cigarettes versus nicotine replacement therapy. Health Technol Assess. 2023 Jul;27(13):1–53. doi: https://doi.org/10.3310/AGTH6901 DOI: https://doi.org/10.3310/AGTH6901
  58. Benowitz NL, Burbank AD. Cardiovascular toxicity of nicotine: implications for electronic cigarette use. Trends Cardiovasc Med. 2016 Aug;26(6):515–23. doi: https://doi.org/10.1016/j.tcm.2016.03.001 DOI: https://doi.org/10.1016/j.tcm.2016.03.001
  59. Chen C, Huo C, Mattey-Mora PP, Bidulescu A, Parker MA. Assessing the association between e-cigarette use and cardiovascular disease: A meta-analysis of exclusive and dual use with combustible cigarettes. Addict Behav. 2024 Oct;157:108086. doi: https://doi.org/10.1016/j.addbeh.2024.108086 DOI: https://doi.org/10.1016/j.addbeh.2024.108086
  60. National Institute for Health and Care Excellence (NICE), Tobacco: preventing uptake, promoting quitting and treating dependence. 2023.
  61. Tabuchi T, Gallus S, Shinozaki T, Nakaya T, Kunugita N, Colwell B. Heat-not-burn tobacco product use in Japan: its prevalence, predictors and perceived symptoms from exposure to secondhand heat-not-burn tobacco aerosol. Tob Control. 2018 Jul;27 e1:e25–33. doi: https://doi.org/10.1136/tobaccocontrol-2017-053947 DOI: https://doi.org/10.1136/tobaccocontrol-2017-053947
  62. Cohen JE, Gartner C, Edwards R, Hammond D. Australia tightens its prescription-only regulation of e-cigarettes. BMJ. 2023 Jun;381:1216. doi: https://doi.org/10.1136/bmj.p1216 DOI: https://doi.org/10.1136/bmj.p1216
  63. Federal Department of Home Affairs FDHA. E-Zigaretten Politik in den Kantonen. 2023; Available from: https://www.bag.admin.ch/bag/de/home/strategie-und-politik/politische-auftraege-und-aktionsplaene/politische-auftraege-zur-tabakpraevention/tabakpolitik-kantone/e-zigarette.html
  64. Bundesamt für Gesundheit BAG. Neues Tabakproduktegesetz. 2024; Available from: https://www.bag.admin.ch/bag/de/home/strategie-und-politik/politische-auftraege-und-aktionsplaene/politische-auftraege-zur-tabakpraevention/tabakpolitik-schweiz/tabpg.html
  65. Ruggia L. Novel nicotine products in Switzerland: A major threat to public health. Tob Prev Cessat. 2022 Nov;8(November):40. doi: https://doi.org/10.18332/tpc/155938 DOI: https://doi.org/10.18332/tpc/155938
  66. Mendelsohn C, Wodak A, Hall W. How should nicotine vaping be regulated in Australia? Drug Alcohol Rev. 2023 Jul;42(5):1288–94. doi: https://doi.org/10.1111/dar.13663 DOI: https://doi.org/10.1111/dar.13663
  67. Saffer H, Dench D, Grossman M, Dave D. E-Cigarettes and Adult Smoking: evidence from Minnesota. J Risk Uncertain. 2020 Jun;60(3):207–28. doi: https://doi.org/10.1007/s11166-020-09326-5 DOI: https://doi.org/10.1007/s11166-020-09326-5
  68. Hackshaw A, Morris JK, Boniface S, Tang JL, Milenković D. Low cigarette consumption and risk of coronary heart disease and stroke: meta-analysis of 141 cohort studies in 55 study reports. BMJ. 2018 Jan;360:j5855. doi: https://doi.org/10.1136/bmj.j5855 DOI: https://doi.org/10.1136/bmj.j5855
  69. Shahab L, Goniewicz ML, Blount BC, Brown J, McNeill A, Alwis KU, et al. Nicotine, Carcinogen, and Toxin Exposure in Long-Term E-Cigarette and Nicotine Replacement Therapy Users: A Cross-sectional Study. Ann Intern Med. 2017 Mar;166(6):390–400. doi: https://doi.org/10.7326/M16-1107 DOI: https://doi.org/10.7326/M16-1107
  70. Merz L, Puhan MA. Taxation options for nicotine and tobacco products in Switzerland - a review of tax policies. Swiss Med Wkly. 2021 Dec;151(5152):w30083. doi: https://doi.org/10.4414/SMW.2021.w30083 DOI: https://doi.org/10.4414/SMW.2021.w30083
  71. Odani S, Tabuchi T. Prevalence and denial of current tobacco product use: combustible and heated tobacco products, Japan, 2022. Prev Med Rep. 2022 Oct;30:102031. doi: https://doi.org/10.1016/j.pmedr.2022.102031 DOI: https://doi.org/10.1016/j.pmedr.2022.102031
  72. Sun T, Anandan A, Lim CC, East K, Xu SS, Quah AC, et al. Global prevalence of heated tobacco product use, 2015-22: A systematic review and meta-analysis. Addiction. 2023 Aug;118(8):1430–44. doi: https://doi.org/10.1111/add.16199 DOI: https://doi.org/10.1111/add.16199
  73. Stoklosa M, Cahn Z, Liber A, Nargis N, Drope J. Effect of IQOS introduction on cigarette sales: evidence of decline and replacement. Tob Control. 2020 Jul;29(4):381–7. DOI: https://doi.org/10.1136/tobaccocontrol-2019-054998
  74. Cummings KM, Nahhas GJ, Sweanor DT. What Is Accounting for the Rapid Decline in Cigarette Sales in Japan? Int J Environ Res Public Health. 2020 May;17(10):3570. doi: https://doi.org/10.3390/ijerph17103570 DOI: https://doi.org/10.3390/ijerph17103570
  75. Odani S, Tsuno K, Agaku IT, Tabuchi T. Heated tobacco products do not help smokers quit or prevent relapse: a longitudinal study in Japan. Tob Control. 2023 Feb;33(4):472–80. doi: https://doi.org/10.1136/tc-2022-057613 DOI: https://doi.org/10.1136/tc-2022-057613
  76. Gallus S, Borroni E, Odone A, van den Brandt PA, Gorini G, Spizzichino L, et al.; The Role of Novel. The Role of Novel (Tobacco) Products on Tobacco Control in Italy. Int J Environ Res Public Health. 2021 Feb;18(4):1895. doi: https://doi.org/10.3390/ijerph18041895 DOI: https://doi.org/10.3390/ijerph18041895
  77. US Food and Drug Administration. FDA Authorizes Marketing of IQOS Tobacco Heating System with ‘Reduced Exposure’ Information. 2020; Available from: https://www.fda.gov/news-events/press-announcements/fda-authorizes-marketing-iqos-tobacco-heating-system-reduced-exposure-information
  78. St Helen G, Jacob Iii P, Nardone N, Benowitz NL. IQOS: examination of Philip Morris International’s claim of reduced exposure. Tob Control. 2018 Nov;27 Suppl 1:s30–6. doi: https://doi.org/10.1136/tobaccocontrol-2018-054321 DOI: https://doi.org/10.1136/tobaccocontrol-2018-054321
  79. Sutanto E, Miller CR, Smith DM, O’Connor RJ, Gravely S, Hammond D, et al. Perceived relative harm of heated tobacco products (IQOS), e-cigarettes, and cigarettes among adults in Canada: findings from the ITC Project. Tob Induc Dis. 2020 Sep;18(September):81. doi: https://doi.org/10.18332/tid/127233 DOI: https://doi.org/10.18332/tid/127233
  80. Glantz SA. Heated tobacco products: the example of IQOS. Tob Control. 2018 Nov;27 Suppl 1:s1–6. doi: https://doi.org/10.1136/tobaccocontrol-2018-054601 DOI: https://doi.org/10.1136/tobaccocontrol-2018-054601
  81. Drovandi A, Salem S, Barker D, Booth D, Kairuz T. Human Biomarker Exposure From Cigarettes Versus Novel Heat-Not-Burn Devices: A Systematic Review and Meta-Analysis. Nicotine Tob Res. 2020 Jun;22(7):1077–85. doi: https://doi.org/10.1093/ntr/ntz200 DOI: https://doi.org/10.1093/ntr/ntz200
  82. National Cancer Institute and Centers for Disease Control and Prevention, Smokeless Tobacco and Public Health: A Global Perspective. 2014.
  83. Rutqvist LE, Curvall M, Hassler T, Ringberger T, Wahlberg I. Swedish snus and the GothiaTek® standard. Harm Reduct J. 2011 May;8(1):11. doi: https://doi.org/10.1186/1477-7517-8-11 DOI: https://doi.org/10.1186/1477-7517-8-11
  84. Robichaud MO, Seidenberg AB, Byron MJ. Tobacco companies introduce ‘tobacco-free’ nicotine pouches. Tob Control. 2020 Dec;29 e1:e145–6. DOI: https://doi.org/10.1136/tobaccocontrol-2019-055321
  85. Clarke E, Thompson K, Weaver S, Thompson J, O’Connell G. Snus: a compelling harm reduction alternative to cigarettes. Harm Reduct J. 2019 Nov;16(1):62. doi: https://doi.org/10.1186/s12954-019-0335-1 DOI: https://doi.org/10.1186/s12954-019-0335-1
  86. Bundesamt für Gesundheit BAG, Informationsschreiben: Das Verbot von Tabakerzeugnissen zum oralen Gebrauch (Art. 5 TabV) ist nicht mehr anzuwenden 2019.
  87. Tobacco Tactics University of Bath. Nicotine Pouches. 2024; Available from: https://tobaccotactics.org/article/nicotine-pouches/
  88. Official Statistics of Sweden, National public health survey. 2022.
  89. Patel M, Kierstead EC, Kreslake J, Schillo BA. Patterns of oral nicotine pouch use among U.S. adolescents and young adults. Prev Med Rep. 2023 May;34:102239. doi: https://doi.org/10.1016/j.pmedr.2023.102239 DOI: https://doi.org/10.1016/j.pmedr.2023.102239
  90. Statistics Norway. Almost twice as many daily users of snus as daily smokders. 2022; Available from: https://www.ssb.no/en/helse/helseforhold-og-levevaner/statistikk/royk-alkohol-og-andre-rusmidler/tobacco-alcohol-and-other-drugs/almost-twice-as-many-daily-users-of-snus-as-daily-smokers
  91. US Food and Drug Administration. FDA authorizes modified risk tobacco products. 2020; Available from: https://www.fda.gov/tobacco-products/advertising-and-promotion/fda-authorizes-modified-risk-tobacco-products
  92. Duren M, Atella L, Welding K, Kennedy RD. Nicotine pouches: a summary of regulatory approaches across 67 countries. Tob Control. 2023 Feb;33 e1:e32–40. doi: https://doi.org/10.1136/tc-2022-057734 DOI: https://doi.org/10.1136/tc-2022-057734
  93. Lunell E, Fagerström K, Hughes J, Pendrill R. Pharmacokinetic Comparison of a Novel Non-tobacco-Based Nicotine Pouch (ZYN) With Conventional, Tobacco-Based Swedish Snus and American Moist Snuff. Nicotine Tob Res. 2020 Oct;22(10):1757–63. doi: https://doi.org/10.1093/ntr/ntaa068 DOI: https://doi.org/10.1093/ntr/ntaa068
  94. McAdam KG, Kimpton H, Faizi A, Porter A, Rodu B. The composition of contemporary American and Swedish smokeless tobacco products. BMC Chem. 2019 Mar;13(1):31. doi: https://doi.org/10.1186/s13065-019-0548-0 DOI: https://doi.org/10.1186/s13065-019-0548-0
  95. Digard H, Proctor C, Kulasekaran A, Malmqvist U, Richter A. Determination of nicotine absorption from multiple tobacco products and nicotine gum. Nicotine Tob Res. 2013 Jan;15(1):255–61. doi: https://doi.org/10.1093/ntr/nts123 DOI: https://doi.org/10.1093/ntr/nts123
  96. McEwan M, Azzopardi D, Gale N, Camacho OM, Hardie G, Fearon IM, et al. A Randomised Study to Investigate the Nicotine Pharmacokinetics of Oral Nicotine Pouches and a Combustible Cigarette. Eur J Drug Metab Pharmacokinet. 2022 Mar;47(2):211–21. doi: https://doi.org/10.1007/s13318-021-00742-9 DOI: https://doi.org/10.1007/s13318-021-00742-9
  97. Vansickel A, Baxter S, Sherwood N, Kong M, Campbell L. Human Abuse Liability Assessment of Tobacco and Nicotine Products: Approaches for Meeting Current Regulatory Recommendations. Nicotine Tob Res. 2022 Feb;24(3):295–305. doi: https://doi.org/10.1093/ntr/ntab183 DOI: https://doi.org/10.1093/ntr/ntab183
  98. Digard H, Errington G, Richter A, McAdam K. Patterns and behaviors of snus consumption in Sweden. Nicotine Tob Res. 2009 Oct;11(10):1175–81. doi: https://doi.org/10.1093/ntr/ntp118 DOI: https://doi.org/10.1093/ntr/ntp118
  99. Benowitz NL. Pharmacology of nicotine: addiction, smoking-induced disease, and therapeutics. Annu Rev Pharmacol Toxicol. 2009;49(1):57–71. doi: https://doi.org/10.1146/annurev.pharmtox.48.113006.094742 DOI: https://doi.org/10.1146/annurev.pharmtox.48.113006.094742
  100. Hecht SS. Smokeless tobacco and its constituents. In: Baan RA, Stewart BW, Straif K, editors. Tumour Site Concordance and Mechanisms of Carcinogenesis. Lyon, FR; 2019.
  101. Lawler TS, Stanfill SB, Tran HT, Lee GE, Chen PX, Kimbrell JB, et al. Chemical analysis of snus products from the United States and northern Europe. PLoS One. 2020 Jan;15(1):e0227837. doi: https://doi.org/10.1371/journal.pone.0227837 DOI: https://doi.org/10.1371/journal.pone.0227837
  102. Osterdahl BG, Jansson C, Paccou A. Decreased levels of tobacco-specific N-nitrosamines in moist snuff on the Swedish market. J Agric Food Chem. 2004 Aug;52(16):5085–8. doi: https://doi.org/10.1021/jf049931a DOI: https://doi.org/10.1021/jf049931a
  103. Wyss AB, Hashibe M, Lee YA, Chuang SC, Muscat J, Chen C, et al. Smokeless Tobacco Use and the Risk of Head and Neck Cancer: Pooled Analysis of US Studies in the INHANCE Consortium. Am J Epidemiol. 2016 Nov;184(10):703–16. doi: https://doi.org/10.1093/aje/kww075 DOI: https://doi.org/10.1093/aje/kww075
  104. Rostron BL, Chang JT, Anic GM, Tanwar M, Chang CM, Corey CG. Smokeless tobacco use and circulatory disease risk: a systematic review and meta-analysis. Open Heart. 2018 Oct;5(2):e000846. doi: https://doi.org/10.1136/openhrt-2018-000846 DOI: https://doi.org/10.1136/openhrt-2018-000846
  105. Hajat C, Stein E, Ramstrom L, Shantikumar S, Polosa R. The health impact of smokeless tobacco products: a systematic review. Harm Reduct J. 2021 Dec;18(1):123. doi: https://doi.org/10.1186/s12954-021-00557-6 DOI: https://doi.org/10.1186/s12954-021-00557-6
  106. Lee PN. Summary of the epidemiological evidence relating snus to health. Regul Toxicol Pharmacol. 2011 Mar;59(2):197–214. doi: https://doi.org/10.1016/j.yrtph.2010.12.002 DOI: https://doi.org/10.1016/j.yrtph.2010.12.002
  107. Valen H, Becher R, Vist GE, Holme JA, Mdala I, Elvsaas IØ, et al. A systematic review of cancer risk among users of smokeless tobacco (Swedish snus) exclusively, compared with no use of tobacco. Int J Cancer. 2023 Dec;153(12):1942–53. doi: https://doi.org/10.1002/ijc.34643 DOI: https://doi.org/10.1002/ijc.34643
  108. Hansson J, Galanti MR, Hergens MP, Fredlund P, Ahlbom A, Alfredsson L, et al. Use of snus and acute myocardial infarction: pooled analysis of eight prospective observational studies. Eur J Epidemiol. 2012 Oct;27(10):771–9. doi: https://doi.org/10.1007/s10654-012-9704-8 DOI: https://doi.org/10.1007/s10654-012-9704-8
  109. Hansson J, Galanti MR, Hergens MP, Fredlund P, Ahlbom A, Alfredsson L, et al. Snus (Swedish smokeless tobacco) use and risk of stroke: pooled analyses of incidence and survival. J Intern Med. 2014 Jul;276(1):87–95. doi: https://doi.org/10.1111/joim.12219 DOI: https://doi.org/10.1111/joim.12219
  110. Titova OE, Baron JA, Michaëlsson K, Larsson SC. Swedish snuff (snus) and risk of cardiovascular disease and mortality: prospective cohort study of middle-aged and older individuals. BMC Med. 2021 May;19(1):111. doi: https://doi.org/10.1186/s12916-021-01979-6 DOI: https://doi.org/10.1186/s12916-021-01979-6
  111. Arefalk G, Hambraeus K, Lind L, Michaëlsson K, Lindahl B, Sundström J. Discontinuation of smokeless tobacco and mortality risk after myocardial infarction. Circulation. 2014 Jul;130(4):325–32. doi: https://doi.org/10.1161/CIRCULATIONAHA.113.007252 DOI: https://doi.org/10.1161/CIRCULATIONAHA.113.007252
  112. Byhamre ML, Araghi M, Alfredsson L, Bellocco R, Engström G, Eriksson M, et al. Swedish snus use is associated with mortality: a pooled analysis of eight prospective studies. Int J Epidemiol. 2021 Jan;49(6):2041–50. doi: https://doi.org/10.1093/ije/dyaa197 DOI: https://doi.org/10.1093/ije/dyaa197
  113. Norwegian Institute of Public Health, Health risks of Scandinavian snus consumption (English summary). 2014.
  114. velo. Available from: velo.com/ch
  115. Ling PM, Hrywna M, Talbot EM, Lewis MJ. Tobacco-Derived Nicotine Pouch Brands and Marketing Messages on Internet and Traditional Media: content Analysis. JMIR Form Res. 2023 Feb;7:e39146. doi: https://doi.org/10.2196/39146 DOI: https://doi.org/10.2196/39146
  116. Azzopardi D, Liu C, Murphy J. Chemical characterization of tobacco-free “modern” oral nicotine pouches and their position on the toxicant and risk continuums. Drug Chem Toxicol. 2022 Sep;45(5):2246–54. doi: https://doi.org/10.1080/01480545.2021.1925691 DOI: https://doi.org/10.1080/01480545.2021.1925691
  117. Azzopardi D, Haswell LE, Frosina J, McEwan M, Gale N, Thissen J, et al. Assessment of biomarkers of exposure and potential harm, and physiological and subjective health measures in exclusive users of nicotine pouches and current, former and never smokers. Biomarkers. 2023 Feb;28(1):118–29. doi: https://doi.org/10.1080/1354750X.2022.2148747 DOI: https://doi.org/10.1080/1354750X.2022.2148747
  118. Ebbert JO, Elrashidi MY, Stead LF. Interventions for smokeless tobacco use cessation. Cochrane Database Syst Rev. 2015 Oct;2015(10):CD004306. DOI: https://doi.org/10.1002/14651858.CD004306.pub5
  119. Hendlin YH, Elias J, Ling PM. The Pharmaceuticalization of the Tobacco Industry. Ann Intern Med. 2017 Aug;167(4):278–80. doi: https://doi.org/10.7326/M17-0759 DOI: https://doi.org/10.7326/M17-0759
  120. Dubrosa F, Sangiuolo K, Franco J Jr, Milanaik RL. Quick nic: novel smokeless nicotine products and pediatric trends. Curr Opin Pediatr. 2023 Aug;35(4):500–12. doi: https://doi.org/10.1097/MOP.0000000000001270 DOI: https://doi.org/10.1097/MOP.0000000000001270
  121. Etter JF. Addiction to the nicotine gum in never smokers. BMC Public Health. 2007 Jul;7(1):159. doi: https://doi.org/10.1186/1471-2458-7-159 DOI: https://doi.org/10.1186/1471-2458-7-159
  122. Borowiecki M, Emery SL, Kostygina G. New recreational nicotine lozenges, tablets, gummies and gum proliferate on the US market. Tob Control. 2024 Apr;33(3):414–6. doi: https://doi.org/10.1136/tc-2022-057673 DOI: https://doi.org/10.1136/tc-2022-057673
  123. King BA, Toll BA. Commentary on Wackowski et al.: Opportunities and Considerations for Addressing Misperceptions About the Relative Risks of Tobacco Products among Adult Smokers. Addiction. 2023 Oct;118(10):1892–4. doi: https://doi.org/10.1111/add.16296 DOI: https://doi.org/10.1111/add.16296

Most read articles by the same author(s)